IT’S been the year of the fat jab. From Mounjaro to Wegovy, weight-loss injections have been THE top health topic. But there ...

Across social media and encrypted messaging apps, a new frontier of weight loss is unfolding in real time, with people ...

Losing weight hasn’t quite been the hardest part of modern obesity treatment. Keeping it off is. That’s exactly the problem Eli Lilly (LLY) seems to have cracked with its weight-loss pill. In a ...

The regulatory submission, filed on December 19, represents the most critical pipeline milestone for Novo Nordisk this year. CagriSema is a combination of two agents: semaglutid (the active ingredient ...

The IEA's annual report outlines how global electricity use from data centers is likely to double by 2030, with AI-centric ...

Social media advertisements of weight-loss drugs such as Wegovy and Mounjaro is illegal as per the India law, lawyers tell ...

The global obesity epidemic has spurred pharmaceutical companies to invest heavily in developing effective weight management solutions, leading to a surge in clinical trials for anti-obesity ...

The White House announced new agreements with nine pharmaceutical companies to lower prescription drug prices Friday.

Trump and nine major pharmaceutical companies struck deals to lower drug prices for cash payers and Medicaid, with over $150 billion pledged for U.S. R&D and manufacturing.

Country is facing epidemic of diabetes and obesity, but experts say widespread and unregulated use of weight loss drugs could put patients at risk ...

Bank of America reaffirmed its Buy rating for Eli Lilly, setting a price target of $1,268. Analyst Jason Gerberry noted that the trial data strengthens the company's competitive stance against rival ...